Triad Financial Advisors, Inc. Gilead Sciences, Inc. Transaction History

Triad Financial Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $14,395 - $20,667	231 Added 6.3%	3,899 $334,000
Q3 2022 Nov 04, 2022	BUY	$59.54 - $68.01 $2,619 - $2,992	44 Added 1.21%	3,668 $226,000
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $1,789 - $2,015	31 Added 0.86%	3,624 $224,000
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $16,275 - $20,394	-281 Reduced 7.25%	3,593 $214,000
Q4 2021 May 09, 2022	BUY	$64.88 - $73.64 $251,345 - $285,281	3,874 New	3,874 $281,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Triad Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Triad Financial Advisors, Inc. with notifications on news.